Deva Holding AS | DEVA - 销售收入

金融业

TRY

TRY 12.93B

现金及等价物

TRY 775.92M

TRY 991.13M

TRY 9.13B

TRY 6.43B

TRY 5.3B

股息收益率

0.18

TRY 820.88M

TRY 882.9M

EPS每股收益

TRY 2.92

股本和储备

TRY 5.79B

TRY 1.32B

债务利息支出

TRY 272.53M

TRY 559.97M

TRY 13.13B

TRY 583.98M

TRY 1.35B

TRY 964.87M

普通股股本

TRY 200.02M

6.55

TRY 2.32B

销售和管理费用

TRY 462.26M

贸易债权人

TRY 809.81M

应收帐款人

TRY 3.03B

	销售	更改		日
Akebia Therapeutics	USD 57.62M		1.14M	2025-12
Alaunos Therapeutics	USD 2K		2K	2025-03
Avita Medical	AUD 17.61M		805K	2025-12
Deva Holding AS	TRY 2.32B		418.58M	2023-09
Dianthus Therapeutics	USD 284K		112K	2025-12
Ionis Pharmaceuticals	USD 246M		43M	2026-03
IQVIA Holdings	USD 4.15B		210M	2026-03
Moderna	USD 389M		289M	2026-03
Organon & Co	USD 1.46B		50M	2026-03
Revvity	USD 711M		61.06M	2026-03
Tectonic Therapeutic	USD 0		0	2024-12
Viatris	USD 3.52B		180M	2026-03
Xeris Pharmaceuticals	USD 83.13M		2.68M	2026-03